<DOC>
	<DOCNO>NCT00701441</DOCNO>
	<brief_summary>Obstructive Sleep Apnea ( OSA ) common sleep disorder affect 9-24 percent middle age adult , become increasingly implicate pathogenesis hypertension , cardiovascular disorder . Up half patient OSA hypertension , risk develop hypertension increase increase severity Sleep Apnea . Patients OSA hypertension endothelial dysfunction , believe precursor cardiovascular disorder . The upper airway collapse obstruction occur OSA result pattern intermittent hypoxia , show cause hypertension , endothelial dysfunction find patient OSA . Intermittent hypoxia result oxidative stress , turn link pathogenesis hypertension endothelial dysfunction . This protocol evaluate role oxidative stress endothelial function blood pressure patient OSA . This pilot clinical study compare oxidative stress parameter , endothelial function patient OSA start treatment continuous positive airway pressure ( CPAP ) 12 week post CPAP . These patient compare control patient history OSA . study involve assignement different treatment . All patient receive indicate treatment OSA measurement collect 12 week adequate treatment .</brief_summary>
	<brief_title>The Role Oxidative Stress Cardiovascular Consequences Sleep Apnea</brief_title>
	<detailed_description>Obstructive Sleep Apnea ( OSA ) increasingly recognize cardiovascular risk factor . OSA cause hypertension strong association atherosclerosis , coronary heart disease , diabetes stroke , fatal cardiovascular event . Endothelial dysfunction preclinical vascular abnormality predict subsequent development vascular disease . Patients OSA demonstrate endothelial dysfunction absence manifest vascular disease . The mechanism endothelial dysfunction OSA largely unknown . Endothelial dysfunction OSA reversible antioxidant , suggest role oxidant overproduction decrease NO availability OSA . This provide parallel cardiovascular disease oxidative stress induce endothelial dysfunction important . Recent study report evidence dysfunction decrease expression endothelial nitric oxide synthase ( eNOS ) association increase peroxynitrite harvest venous endothelial cell OSA patient . We endeavor perform first direct quantification microvascular endothelial gene OSA patient . We hypothesize patient OSA free cardiovascular disease early functional change microcirculatory endothelial cell associate OSA , therefore would resolve treatment . Given role oxidative stress vascular disease OSA , expect find evidence superoxide overproduction microcirculatory vessel . We expect functional change reversible treatment OSA . Measurement superoxide do subcutaneous biopsy tissue use quantitative Polymerase Chain Reaction ( qPCR ) immunohistochemistry technique image analysis software . Measurement endothelial function do use Doppler ultrasound .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Completed sleep study Older 18 Hypertension Diabetes coronary disease Peripheral vascular disease High cholesterol Smoking Pregnancy Use erectile dysfunction medication supplement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>sleep apnea ,</keyword>
	<keyword>oxidative stress</keyword>
</DOC>